Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 981

The DOI matches its Crossref record.

Solid lipid nanoparticles

Mehnert, Wolfgang, Mäder, Karsten·2012·Advanced Drug Delivery Reviews
DOI 10.1016/j.addr.2012.09.021
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2012.09.021

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 161

  1. Sandow, 1990, Pharmacokinetics and endocrine effects of slow release formulation of LHRH analogues, J. Steroid Biochem. Mol. Biol., 37, 925, 10.1016/0960-0760(90)90445-Q · doi:10.1016/0960-0760(90)90445-q
  2. Sipos, 1997, Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors, Cancer Chemother. Pharmacol., 39, 383, 10.1007/s002800050588 · DOI
  3. Müller, 1996, Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique, Pharm. Res., 13, 32, 10.1023/A:1016064930502 · DOI
  4. Scheffel, 1970, Albumin microspheres for study of the reticuloendothelial system, J. Nucl. Med., 13, 498
  5. Allémann, 1993, Drug loaded nanoparticles — preparation methods and drug targeting issues, Eur. J. Pharm. Biopharm., 39, 173
  6. Kopecek, 1999, HPMA copolymer-bound anticancer drugs: mechanism of action on cellular and subcellular levels, Proc. Int. Symp. Controlled Rel. Bioact. Mater., 26, 24
  7. Al-Khouri-Fallouh, 1986, Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules, Int. J. Pharm., 28, 125, 10.1016/0378-5173(86)90236-X · DOI
  8. Damge, 1990, Nanocapsules as carriers for oral peptide delivery, J. Controlled Rel., 13, 233, 10.1016/0168-3659(90)90013-J · DOI · Paper page
  9. Smith, 1986, Evaluation of polylactid as a biodegradable drug delivery system for parenteral administration, Int. J. Pharm., 30, 215, 10.1016/0378-5173(86)90081-5 · DOI
  10. Senior, 1987, Fate and behaviour of liposomes in vivo. A review of controlling factors, Crit. Rev. Ther. Drug Carrier Syst., 3, 123
  11. Woodle, 1992, Sterically stabilized liposomes, Biochim. Biophys. Acta, 1113, 171, 10.1016/0304-4157(92)90038-C · DOI · Paper page
  12. Huang, 1992, Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-12 colon carcinoma, Cancer Res., 52, 6774
  13. Gabizon, 1994, Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes, Cancer Res., 54, 987
  14. Torchilin, 1985, Liposomes as targetable drug carriers, Crit. Rev. Ther. Drug Carrier Syst., 2, 65
  15. Senior, 1991, Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles, Biochim. Biophys. Acta, 1062, 77, 10.1016/0005-2736(91)90337-8 · DOI · Paper page
  16. Torchilin, 1994, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity, Biochim. Biophys. Acta, 1195, 11, 10.1016/0005-2736(94)90003-5 · DOI · Paper page
  17. Martin, 1982, Irreversible coupling of immunoglobulin fragments to preformed vesicles, J. Biol. Chem., 257, 286, 10.1016/S0021-9258(19)68359-6 · DOI · Paper page
  18. Allen, 1994, Long-circulating (sterically stabilized) liposomes for targeted drug delivery, Trends Pharmacol. Sci., 15, 215, 10.1016/0165-6147(94)90314-X · DOI · Paper page
  19. Janknecht, 1992, Liposomal and lipid formulations of amphotericin B, Clin. Pharmacokinet., 23, 279, 10.2165/00003088-199223040-00004 · DOI · Paper page
  20. Couvreur, 1995, Controlled drug delivery with nanoparticles: current possibilities and future trends, Eur. J. Pharm. Biopharm., 41, 2
  21. Merisko-Liversidge, 1996, Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs, Pharm. Res., 13, 272, 10.1023/A:1016051316815 · DOI · Paper page
  22. Müller, 1998, Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique, Int. J. Pharm., 160, 229, 10.1016/S0378-5173(97)00311-6 · DOI · Paper page
  23. Ford, 1999, Nanospheres of cyclosporin A: poor oral absorption in dogs, Int. J. Pharm., 183, 3, 10.1016/S0378-5173(99)00049-6 · DOI
  24. Wretlind, 1981, Development of fat emulsions, J. Parenter. Enter. Nutr., 5, 230, 10.1177/0148607181005003230 · DOI
  25. Collins-Gold, 1990, Parenteral emulsions for drug delivery, Adv. Drug. Deliv. Rev., 5, 189, 10.1016/0169-409X(90)90016-L · doi:10.1016/0169-409x(90)90016-l
  26. Prankerd, 1990, The use of oil-in-water emulsions as a vehicle for parenteral drug administration, J. Parent. Sci. Technol., 44, 139
  27. Venkataram, 1990, Pharmacokinetics of two alternative dosage forms for cyclosporine: Liposomes and Intralipid, J. Pharm. Sci., 79, 216, 10.1002/jps.2600790307 · DOI
  28. Davis, 1974, Pharmaceutical aspects of intravenous fat emulsions, Am. J. Hosp. Pharm., 31, 149
  29. Davis, 1976, The emulsion-obsolete dosage form or novel drug delivery system and therapeutic agent?, J. Clin. Pharm., 1, 11
  30. Elbaz, 1993, Positively charged submicron emulsions — a new type of colloidal drug carrier, Int. J. Pharm., 96, R1, 10.1016/0378-5173(93)90237-A · DOI
  31. Müller, 1994, Fat emulsions for parenteral nutrition IV: Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with high electrolyte load, Int. J. Pharm., 107, 121, 10.1016/0378-5173(94)90449-9 · doi:10.1016/0378-5173(94)90449-9
  32. Davis, 1987, Lipid emulsions as drug delivery systems, Ann. N.Y. Acad. Sci., 507, 75, 10.1111/j.1749-6632.1987.tb45793.x · doi:10.1111/j.1749-6632.1987.tb45793.x
  33. Graham, 1977, Thrombophlebitis after intravenous diazepam — can it be prevented, Anesth. Analg., 56, 409, 10.1213/00000539-197705000-00020 · doi:10.1213/00000539-197705000-00020
  34. Levy, 1989, Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use, Int. J. Pharm., 54, 103, 10.1016/0378-5173(89)90329-3 · DOI
  35. Jumaa, 2000, Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect, Eur. J. Pharm. Sci., 9, 285, 10.1016/S0928-0987(99)00071-8 · DOI
  36. Magenheim, 1993, A new in vitro technique for evaluation of drug release profile from colloidal carriers — ultrafiltration technique at low pressure, Int. J. Pharm., 94, 115, 10.1016/0378-5173(93)90015-8 · DOI · Paper page
  37. Benita, 1986, Pharmacological evaluation of an injectable prolonged release emulsion of physiostigmine in rabbits, J. Pharm. Pharmacol., 38, 653, 10.1111/j.2042-7158.1986.tb03104.x · DOI
  38. Benita, 1986, Physiostigmine emulsions: a new injectable controlled release delivery system, Int. J. Pharm., 30, 47, 10.1016/0378-5173(86)90134-1 · DOI
  39. Eldem, 1991, Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy, Pharm. Res., 8, 47, 10.1023/A:1015874121860 · DOI
  40. Domb, 1995, Long acting injectable oxytetracycline-liposphere formulation, Int. J. Pharm., 124, 271, 10.1016/0378-5173(95)00098-4 · doi:10.1016/0378-5173(95)00098-4
  41. Domb, 1993, Liposphere parenteral delivery system, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 346
  42. Siekmann, 1992, Submicron-sized parenteral carrier systems based on solid lipids, Pharm. Pharmacol. Lett., 1, 123
  43. Müller, 1995, Solid lipid nanoparticles (SLN) — An alternative colloidal carrier system for controlled drug delivery, Eur. J. Pharm. Biopharm., 41, 62
  44. Sjöström, 1992, Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate, Int. J. Pharm., 88, 53, 10.1016/0378-5173(92)90303-J · DOI · Paper page
  45. Cavalli, 1993, Solid lipospheres of doxorubicin and idarubicin, Int. J. Pharm., 89, R9, 10.1016/0378-5173(93)90313-5 · doi:10.1016/0378-5173(93)90313-5
  46. Ahlin, 1998, Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions, Acta Pharm., 48, 257
  47. Lippacher, 2000, Investigation on the viscoelastic properties of lipid based colloidal drug carriers, Int. J. Pharm., 196, 227, 10.1016/S0378-5173(99)00428-7 · DOI
  48. zur Mühlen, 1998, Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles, Pharmazie, 53, 552
  49. zur Mühlen, 1998, Solid lipid nanoparticles (SLN) for controlled drug delivery — Drug release and release mechanism, Eur. J. Pharm. Biopharm., 45, 149, 10.1016/S0939-6411(97)00150-1 · DOI · Paper page
  50. Lander, 2000, Gaulin homogenization: a mechanistic study, Biotechnol. Prog., 16, 80, 10.1021/bp990135c · DOI
  51. Siekmann, 1994, Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination, Pharm. Pharmacol. Lett., 3, 194
  52. A. zur Mühlen, Feste Lipid-Nanopartikel mit prolongierter Wirkstoffliberation: Herstellung, Langzeitstabilität, Charakterisierung, Freisetzungsverhalten und mechanismen, Ph.D. Thesis, Free University of Berlin, 1996.
  53. Siekmann, 1996, Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions, Eur. J. Pharm. Biopharm., 43, 104
  54. Moulik, 1998, Structure, dynamics and transport properties of microemulsions, Adv. Coll. Interf. Sci., 78, 99, 10.1016/S0001-8686(98)00063-3 · DOI · Paper page
  55. Gasco, 1997, Solid lipid nanospheres from warm micro-emulsions, Pharm. Tech. Eur., 9, 52
  56. Boltri, 1993, Lipid nanoparticles: Evaluation of some critical formulation parameters, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 346
  57. De Labouret, 1995, Application of an original process for obtaining colloidal dispersions of some coating polymers. Preparation, characterization, industrial scaling up, Drug Dev. Ind. Pharm., 21, 229, 10.3109/03639049509048106 · doi:10.3109/03639049509048106
  58. Cavalli, 1996, Effect of some experimental factors on the production process of solid lipid nanoparticles, Eur. J. Pharm. Biopharm., 43, 110
  59. Gasco, 1992, Optimization of the incorporation of desoxycortisone acetate in lipospheres, Eur. J. Pharm. Biopharm., 38, 7
  60. C. Schwarz, Feste Lipidnanopartikel: Herstellung, Charakterisierung, Arzneistoffinkorporation und -freisetzung, Sterilisation und Lyophilisation, Ph.D. Thesis, Free University of Berlin, 1995.
  61. Cavalli, 1998, The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules, Pharmazie, 53, 392
  62. Sculier, 1986, Intravenous infusion of high doses of liposomes containing NSC 251635, a water insoluble cytostatic agent. A pilot study with pharmacokinetic data, J. Clin. Oncol., 4, 789, 10.1200/JCO.1986.4.5.789 · DOI
  63. Zuidam, 1992, Sterilization of liposomes by heat treatment, Pharm. Res., 10, 1591, 10.1023/A:1018916518515 · DOI
  64. Lukyanov, 1994, Autoclaving of liposomes, J. Microencapsul., 11, 669, 10.3109/02652049409051118 · doi:10.3109/02652049409051118
  65. Schwarz, 1995, Sterilization and physical stability of drug-free and etomidate-loaded solid lipid nanoparticles, Proc. Intern. Symp. Control. Rel. Bioct. Mater., 22, 766
  66. Liedtke, 1999, Physical characterisation of solid lipid nanoparticles (SLN™), Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 599
  67. J.S. Lucks, Parenterale Fettemulsionen als Arzneistoffträger — Herstellung, Charakterisierung und Stabilität, Ph.D. Thesis, Christian Albrechts Universität Kiel, 1993.
  68. C. Freitas, Feste Lipid-Nanopartikel (SLN): Mechanismen der physikalischen Destabilisierung und Stabilisierung, Ph.D. Thesis, Free University of Berlin, 1998.
  69. Cavalli, 1997, Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles, Int. J. Pharm., 148, 47, 10.1016/S0378-5173(96)04822-3 · DOI · Paper page
  70. Heiati, 1998, Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilisation, J. Microencapsul., 15, 173, 10.3109/02652049809006847 · DOI
  71. Pikal, 1990, The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure, Int. J. Pharm., 60, 203, 10.1016/0378-5173(90)90074-E · DOI · Paper page
  72. Crowe, 1992, Stabilization of dry liposomes by carbohydrates, Dev. Biol. Stand., 74, 285
  73. Crowe, 1986, Prevention of fusion and leakage in freeze-dried liposomes by carbohydrates, Biochim. Biophys. Acta, 861, 131, 10.1016/0005-2736(86)90411-6 · doi:10.1016/0005-2736(86)90411-6 · Paper page
  74. Doebbler, 1966, Cryoprotective compounds, Cryobiology, 3, 2, 10.1016/S0011-2240(66)80144-X · DOI
  75. Bensouda, 1989, Freeze-drying of emulsions — influence of congealing on granulometry — research of a cryoprotectant agent, Pharm. Acta Helv., 64, 40
  76. Madden, 1985, Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents, Biochim. Biophys. Acta, 817, 67, 10.1016/0005-2736(85)90069-0 · DOI · Paper page
  77. Strauss, 1986, The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying, Biochim. Biophys. Acta, 858, 169, 10.1016/0005-2736(86)90303-2 · doi:10.1016/0005-2736(86)90303-2
  78. Ausborn, 1992, Stabilization of liposomes by freeze–thaw and lyophilization techniques: problems and opportunities, Eur. J. Pharm. Biopharm., 38, 133
  79. Hauser, 1988, Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration, Adv. Exp. Med. Biol., 238, 71, 10.1007/978-1-4684-7908-9_7 · doi:10.1007/978-1-4684-7908-9_7
  80. Vemuri, 1991, Effect of sugars on freeze–thaw and lyophilization of liposomes, Drug Dev. Ind. Pharm., 17, 327, 10.3109/03639049109043831 · doi:10.3109/03639049109043831
  81. Shulkin, 1984, Lyophilized liposomes: a new method for long-term vesicular storage, J. Microencapsul., 1, 73, 10.3109/02652048409031539 · doi:10.3109/02652048409031539
  82. Mobley, 1994, Phase transition temperature reduction and glass transformation in dehydroprotected lyophilized liposomes, J. Controlled Rel., 31, 73, 10.1016/0168-3659(94)90253-4 · DOI
  83. Schwarz, 1997, Freeze-drying of drug-free and drug-loaded solid lipid nanoparicles, Int. J. Pharm., 157, 171, 10.1016/S0378-5173(97)00222-6 · DOI
  84. Crowe, 1985, Preservation of freeze-dried liposomes by trehalose, Arch. Biochem. Biophys., 242, 240, 10.1016/0003-9861(85)90498-9 · DOI · Paper page
  85. Siekmann, 1994, Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. II. Physicochemical characterization and lyophilisation, Pharm. Pharmacol. Lett., 3, 225
  86. Zimmermann, 2000, Influence of different parameters on reconstitution of lyophilized SLN, Int. J. Pharm., 196, 211, 10.1016/S0378-5173(99)00424-X · DOI
  87. Freitas, 1998, Spray-drying of solid lipid nanoparticles (SLN™), Eur. J. Pharm. Biopharm., 46, 145, 10.1016/S0939-6411(97)00172-0 · DOI · Paper page
  88. Drake, 1989, Imaging crystals polymers and processes in water with the AFM, Science, 243, 1586, 10.1126/science.2928794 · DOI · Paper page
  89. Häberle, 1992, In situ investigations of single living cells infected by viruses, Ultramicroscopy, 1161, 42
  90. Shakesheff, 1994, Visualizing the degradation of polymer surfaces with an Atomic Force Microscope, Proc. Intern. Symp. Control. Rel. Bioact. Mat., 21, 1343
  91. Gref, 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245 · DOI · Paper page
  92. Kirby, 1995, Imaging xanthum gum by atomic force microscopy, Carbohydr. Res., 267, 161, 10.1016/0008-6215(94)00294-P · DOI
  93. zur Mühlen, 1996, Atomic force microscopy studies of solid lipid nanoparticles, Pharm. Res., 13, 1411, 10.1023/A:1016042504830 · DOI · Paper page
  94. Dingler, 1999, Solid lipid nanoparticles (SLN™/Lipopearls™) — a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products, J. Microencapsul., 16, 751, 10.1080/026520499288690 · DOI · Paper page
  95. A. Dingler, Feste Lipid-Nanopartikel als kolloidale Wirkstoffträgersysteme zur dermalen Applikation, Ph.D. Thesis, Free University of Berlin, 1998.
  96. Westesen, 1993, Investigations on the physical state of lipid nanoparticles by synchroton radiation X-ray diffraction, Int. J. Pharm., 93, 189, 10.1016/0378-5173(93)90177-H · DOI · Paper page
  97. Anger, 1999, High resolution size determination of 20nm colloidal gold particles by SedFFF, Pharm. Res., 16, 1743, 10.1023/A:1018962217258 · doi:10.1023/a:1018962217258
  98. Anger, 2000, Charakterisierung von makromolekülen, kolloiden und partikeln mit der field flow fractionation, Pharm. Ind., 62, 150
  99. Anger, 1999, Coating of nanoparticles: analysis of adsorption using sedimentation field–flow fractionation (SdFFF), Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 599
  100. Westesen, 1995, Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?, Int. J. Pharm., 115, 129, 10.1016/0378-5173(94)00347-8 · DOI
  101. V. Jenning, Feste Lipid Nanopartikel als Trägersystem für die dermale Applikation von Retinol, Ph.D. Thesis, Free University of Berlin, 1999.
  102. Zimmermann, 1999, H-NMR as a method to characterize colloidal carrier systems, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 595
  103. H. Weyers, Feste Lipid Nanopartikel (SLN) für die gewebsspezifische Arzneistoffapplikation — Herstellung und Charakterisierung oberflächenmodifizierter Formulierungen, Ph.D. Thesis, Free University of Berlin, 1995.
  104. Almeida, 1997, Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters, Int. J. Pharm., 149, 255, 10.1016/S0378-5173(97)04885-0 · DOI
  105. Jenning, 2000, Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties, J. Controlled Rel., 66, 115, 10.1016/S0168-3659(99)00223-0 · DOI · Paper page
  106. Unruh, 1999, Observation of size dependent melting in lipid nanoparticles, J. Phys. Chem. B, 103, 10373, 10.1021/jp9912612 · DOI
  107. Siekmann, 1994, Electron-microscopic characterization of melt-homogenised solid lipid nanoparticles, Eur. J. Pharm. Sci., 2, 190, 10.1016/0928-0987(94)90459-6 · doi:10.1016/0928-0987(94)90459-6
  108. Siekmann, 1994, Thermoanalysis of the recrystallization of melt-homogenized glyceride nanoparticles, Colloids and surfaces B: Biointerfaces, 3, 159, 10.1016/0927-7765(94)80063-4 · DOI · Paper page
  109. Westesen, 1997, Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles, Int. J. Pharm., 151, 35, 10.1016/S0378-5173(97)04890-4 · DOI · Paper page
  110. Freitas, 1998, Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions, Int. J. Pharm., 168, 221, 10.1016/S0378-5173(98)00092-1 · DOI · Paper page
  111. Freitas, 1999, Stability determination of solid lipid nanoparticles (SLN™) in aqueous dispersion after addition of electrolyte, J. Microencapsul., 16, 59, 10.1080/026520499289310 · DOI
  112. Müller, 1994, Fat emulsions for parenteral nutrition. III. Lipofundin MCT/LCT regimens for parenteral nutrition (TPN) with low electrolyte load, Int. J. Pharm., 101, 175, 10.1016/0378-5173(94)90213-5 · DOI
  113. Bunjes, 1996, Crystallization tendency and polymorphic transitions in triglyceride nanoparticles, Int. J. Pharm., 129, 159, 10.1016/0378-5173(95)04286-5 · DOI · Paper page
  114. Freitas, 1999, Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase, Eur. J. Pharm. Biopharm., 47, 125, 10.1016/S0939-6411(98)00074-5 · DOI · Paper page
  115. Yoshino, 1983, Influence of the fatty acid composition on the properties and polymorphic transition of fatty suppository bases, Chem. Pharm. Bull., 31, 237, 10.1248/cpb.31.237 · doi:10.1248/cpb.31.237
  116. Stoye, 1998, Transformation of liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles — Physico–chemical characterization and influence on drug permeation through the excised human stratum corneum, Eur. J. Pharm. Biopharm., 46, 191, 10.1016/S0939-6411(98)00023-X · DOI
  117. Rapoport, 1998, Effect of Pluronic on the intracellular distribution and intracellular dynamics of a spin-labeled analog of doxorubicin, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 26, 1052
  118. Ahlin, 2000, Influence of spin probe structure on its distribution in SLN dispersions, Int. J. Pharm., 196, 241, 10.1016/S0378-5173(99)00431-7 · doi:10.1016/s0378-5173(99)00431-7
  119. Müller, 2000, Solid lipid nanoparticles (SLN) for controlled drug delivery — A review of the state of art, Eur. J. Pharm. Biopharm., 50, 161, 10.1016/S0939-6411(00)00087-4 · DOI · Paper page
  120. Westesen, 1997, Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential, J. Controlled Rel., 48, 223, 10.1016/S0168-3659(97)00046-1 · DOI · Paper page
  121. Cavalli, 1992, Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters, S.T.P. Pharma Sci., 2, 514
  122. Gasco, 1992, Timolol in lipospheres, Pharmazie, 47, 119
  123. Cavalli, 1995, Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair, Int. J. Pharm., 117, 243, 10.1016/0378-5173(94)00339-7 · doi:10.1016/0378-5173(94)00339-7
  124. Cavalli, 1999, Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrin, Int. J. Pharm., 182, 59, 10.1016/S0378-5173(99)00066-6 · DOI
  125. Morel, 1996, Thymopentin in solid lipid nanoparticles, Int. J. Pharm., 132, 259, 10.1016/0378-5173(95)04388-8 · DOI
  126. Morel, 1994, Incorporation in lipospheres of [D-Trp-6]LHRH, Int. J. Pharm., 105, R1, 10.1016/0378-5173(94)90466-9 · doi:10.1016/0378-5173(94)90466-9
  127. Morel, 1998, NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) complexes, Eur. J. Pharm. Biopharm., 45, 157, 10.1016/S0939-6411(97)00107-0 · DOI
  128. Heiati, 1997, Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate, Int. J. Pharm., 146, 123, 10.1016/S0378-5173(96)04782-5 · DOI
  129. Heiati, 1998, Solid lipid nanoparticles as drug carriers. II. Plasma stability and biodistribution of solid lipid nanoparticles containing the prodrug 3′-azido-3′-deoxythymidine palmitate in mice, Int. J. Pharm., 174, 71, 10.1016/S0378-5173(98)00236-1 · DOI
  130. Yang, 1999, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain, J. Controlled Rel., 59, 299, 10.1016/S0168-3659(99)00007-3 · DOI · Paper page
  131. Yang, 1999, Body distribution of camptothecin solid lipid nanoparticles after oral administration, Pharm. Res., 16, 751, 10.1023/A:1018888927852 · DOI · Paper page
  132. Lukowski, 1997, Electron diffraction of solid lipid nanoparticles loaded with aciclovir, Pharmazie, 52, 642
  133. S.A. Runge, Feste Lipidnanopartikel (SLN™) als kolloidaler Arzneistoffträger für die orale Applikation von Ciclosporin A, Ph.D. Thesis, Free University of Berlin, 1998.
  134. H. Bunjes, Einflußnahme unterschiedlicher Faktoren auf Struktur und Eigenschaften von Nanopartikeln aus festen Triglyceriden. Ph.D. Thesis, Friedrich-Schiller-Universität Jena, 1998.
  135. Ahlin, 1998, EPR study of loading capacity and location of spin-labelled lipophilic substance in different SLN, Proc. Int. Symp. Control. Rel. Bioact. Mater., 25, 334
  136. K. Mäder, Habilitation Thesis, Humboldt University Berlin, 1998.
  137. Olbrich, 1999, Enzymatic degradation of SLN — effect of surfactant and surfactant mixtures, Int. J. Pharm., 180, 31, 10.1016/S0378-5173(98)00404-9 · DOI · Paper page
  138. Metha, 1992, Fat emulsion particle-size distribution in total nutrient admixtures, Am. J. Hosp. Pharm, 49, 2749
  139. Puntis, 1992, Hazards of parenteral treatment: do particles count?, Arch. Dis. Child., 67, 1475, 10.1136/adc.67.12.1475 · doi:10.1136/adc.67.12.1475
  140. Blunk, 1993, Differential adsorption: Effect of plasma protein adsorption patterns on organ distribution of colloidal drug carriers, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 256
  141. Müller, 1997, Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulozytes, J. Controlled Rel., 47, 261, 10.1016/S0168-3659(97)01653-2 · DOI
  142. Müller, 1996, Phagozytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407, J. Drug Target., 4, 161, 10.3109/10611869609015973 · DOI · Paper page
  143. Illum, 1987, The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer-Poloxamine 908, Life Sci., 40, 367, 10.1016/0024-3205(87)90138-X · DOI · Paper page
  144. Rudt, 1993, In vitro uptake of polystyrene latex particles and parenteral fat emulsions by human granulocytes, Int. J. Pharm., 99, 1, 10.1016/0378-5173(93)90315-7 · doi:10.1016/0378-5173(93)90315-7
  145. Müller, 1999, Solid lipid nanoparticles: phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation, 1st communication, Pharm. Ind., 61, 462
  146. Bocca, 1998, Phagozytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles, Int. J. Pharm., 175, 185, 10.1016/S0378-5173(98)00282-8 · DOI
  147. Cavalli, 1999, Albumin adsorption on stealth and non-stealth solid lipid nanoparticles, S.T.P. Pharma Sci., 9, 183
  148. Torchilin, 1995, Which polymers can make nanoparticulate drug carriers long-circulating?, Adv. Drug Del. Rev., 16, 141, 10.1016/0169-409X(95)00022-Y · DOI · Paper page
  149. Mosmann, 1983, Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Meth., 65, 55, 10.1016/0022-1759(83)90303-4 · DOI · Paper page
  150. Müller, 1996, Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles, Int. J. Pharm., 138, 85, 10.1016/0378-5173(96)04539-5 · DOI · Paper page
  151. Maaßen, 1993, Comparison of cytotoxicity between polyester nanoparticles and solid lipid nanoparticles, Proc. Intern. Symp. Control. Rel. Bioact. Mater., 20, 490
  152. Müller, 1996, Phagozytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407, J. Drug Target., 4, 161, 10.3109/10611869609015973 · DOI · Paper page
  153. Borgström, 1980, Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat, Gastroenterology, 78, 954, 10.1016/0016-5085(80)90777-5 · DOI · Paper page
  154. Borgström, 1977, The polar interactions between pancreatic lipase, colipase and the triglyceride substrate, FEBS Lett., 83, 23, 10.1016/0014-5793(77)80633-9 · doi:10.1016/0014-5793(77)80633-9
  155. Scow, 1977, Effect of albumin products formed from chylomicron triacyl-glycerol by lipoprotein lipase in vitro, Biochem. Biophys. Acta, 487, 472, 10.1016/0005-2760(77)90217-X · DOI
  156. Müller, 1999, Solid lipid nanoparticles: phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation, 2nd communication, Pharm. Ind., 61, 564
  157. Müller, 1996, Biodegradation of solid lipid nanoparticles as a function of lipase incubation time, Int. J. Pharm., 144, 115, 10.1016/S0378-5173(96)04731-X · DOI
  158. Bargoni, 1998, Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats, Pharm. Res., 15, 745, 10.1023/A:1011975120776 · DOI
  159. Zara, 1999, Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN), Pharm. Res., 44, 281, 10.1006/phrs.1999.0509 · DOI
  160. Alyautdin, 1997, Delivery of loperamide across the blood–brain barrier with Polysorbate 80-coated polybutylcyanoacrylate nanoparticles, Pharm. Res., 14, 325, 10.1023/A:1012098005098 · DOI · Paper page
  161. Maia, 2000, Solid lipid nanoparticles as drug carriers for topical glucocorticoids, Int. J. Pharm., 196, 165, 10.1016/S0378-5173(99)00413-5 · DOI · Paper page

Cited by

See all 981

Metadata

Authors
Mehnert, W., & Mäder, K.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2012-12
Volume
64
Pages
83-101
ISSN
0169-409X (ISSN-L)
DOI
10.1016/j.addr.2012.09.021
OpenAlex
W1987433127
Cited by
981
References
0
FWCI
4.77
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Solid lipid nanoparticles. https://app.cochat.ai/papers/10.1016/j.addr.2012.09.021
The paper
Mehnert, W., & Mäder, K. (2012). Solid lipid nanoparticles. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2012.09.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.